NCT01023464已完成不适用
Tear Film Break-Up Time Evaluation of FID 114657
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 38
- 主要终点
- tear film break-up time (TFBUT)
研究概览
简要总结
To evaluate the effects of FID 114657 on tear film break-up time in dry eye patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The informed consent document and HIPAA privacy document must be read, signed and dated by the patient or legally authorized representative before conducting any procedures.
- •Patients (minimum age 18) with dry eye. Criteria for the diagnosis must include the following characteristics at Visit 1 (Screening): Patients' self-assessment of dry eye status (answer of at least Some of the time to the question, "How often have your eyes felt dry enough to want to use eye drops?");TFBUT <5 seconds in at least one eye; > Grade 1 for Meibomian Gland Expression in both eyes; Evidence of missing meibomian glands in both eyes.
- •Able and willing to follow study instructions.
- •Patients must have best-corrected visual acuity of 0.6 logMAR or better in each eye as assessed using an ETDRS chart at Visit
- •Patients must not have used any topical ocular drops for approximately 24 hours prior to Visit 1.
排除标准
- •History or evidence of ocular or intraocular surgery in either eye within the past six months.
- •History or evidence of serious ocular trauma in either eye within the past six months.
- •Current punctal occlusion of any type (e.g., collagen plugs, silicone plugs).
- •History of intolerance or hypersensitivity to any component of the study medications.
- •History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia; active or recent varicella viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye.
- •Use of any concomitant topical ocular medications during the study period.
- •Patients using systemic medications that may contribute to dry eye (e.g. cold and allergy medications, tricyclic antidepressants, hormone replacement therapies) may not be enrolled in the study unless they have been on a stable dosing regimen for a minimum of 30 days prior to Visit
- •In addition, the dosing regimen must remain stable throughout the study.
- •Ocular conditions such as conjunctival infections, iritis, or any other ocular condition that may preclude safe administration of the test article.
- •Individuals unwilling to discontinue contact lens wear during the study period. Contact lens wear must have been discontinued at least one week prior to Visit
- •Enrollment of investigator's office staff, relatives, or members of their respective households; or enrollment of more than one member of the same household.
- •Participation in an investigational drug or device study within 30 days of entering this study.
研究组 & 干预措施
Period 1
Other
FID 114657 or SootheXP
干预措施: FID114657 (Other)
Period 1
Other
FID 114657 or SootheXP
干预措施: SootheXP Emollient (Lubricant) Eye Drops (Other)
Period 2
Other
FID 114657 or SootheXP
干预措施: FID114657 (Other)
Period 2
Other
FID 114657 or SootheXP
干预措施: SootheXP Emollient (Lubricant) Eye Drops (Other)
结局指标
主要结局
tear film break-up time (TFBUT)
时间窗: Instill assigned test article to both eyes and begin timing the evaluation process. Measure TFBUT at 15, 30, 60 and 120 minutes post instillation.
次要结局
- Acute comfort(Immediately post instillation of test article)
研究者
相似试验
已完成
不适用
Evaluation of FID 114657 on Tear Film Lipid Layer ThicknessDry EyeNCT00848068Alcon Research40
已完成
不适用
Observation of tear film break-up time in patients with evaporative dry eye symptoms using EvoTears® eye drops compared to eye drops containing lipidsEvaporative dry eye and meibomian gland dysfunctionEye DiseasesOther disorders of lacrimal glandISRCTN15512057RSAPHARM Arzneimittel GmbH30
已完成
不适用
Evaluation of FID 114657 in Dry Eye SubjectsMeibomian Gland DysfunctionNCT01079858Alcon Research49
已完成
3 期
A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult ParticipantsDry Eye SyndromeNCT05878067AbbVie40
已完成
2 期
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up TimeDry Eye DiseaseNCT00760045Alcon Research40